BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17667594)

  • 1. The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer.
    Munkarah AR; Ali-Fehmi R; Jiang JZ; Elhammady E; Malone JM; Saed GM
    Anticancer Drugs; 2007 Sep; 18(8):889-96. PubMed ID: 17667594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells.
    Munkarah AR; Morris R; Baumann P; Deppe G; Malone J; Diamond MP; Saed GM
    J Soc Gynecol Investig; 2002; 9(3):168-73. PubMed ID: 12009392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells.
    Munkarah AR; Genhai Z; Morris R; Baker VV; Deppe G; Diamond MP; Saed GM
    Gynecol Oncol; 2003 Mar; 88(3):429-33. PubMed ID: 12648598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanism of cyclooxygenase-2 inhibitor in inhibition of proliferation of colon cancer cells by modulating Stat5 signal transduction pathway].
    Ma XT; Yu LW; Wang S; Zhang H; Du RY; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2566-9. PubMed ID: 16321305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
    Liu XH; Yao S; Kirschenbaum A; Levine AC
    Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of NS398 on the proliferation of human ovarian cancer cell lines CAOV3 and OVCAR3 in vitro].
    Wang CY; Wang M; Wang XY; Zhang SL; Wang YX; Li LK
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):415-8. PubMed ID: 12921553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase inhibition and hyperthermia for the potentiation of the cytotoxic response in ovarian cancer cells.
    Barnes AP; Miller BE; Kucera GL
    Gynecol Oncol; 2007 Feb; 104(2):443-50. PubMed ID: 16996114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels.
    Bijman MN; Hermelink CA; van Berkel MP; Laan AC; Janmaat ML; Peters GJ; Boven E
    Biochem Pharmacol; 2008 Jan; 75(2):427-37. PubMed ID: 17936723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
    Li Y; Mi C
    Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
    Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
    Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
    Ding XZ; Tong WG; Adrian TE
    Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of gastrin receptor antagonist and cyclooxygenase-2 inhibitor on proliferation and apoptosis of gastric cancer cell].
    Sun WH; Su H; Zhang LJ; Shao Y; Xu HC; Zhang T; Xue YP; Ding GX; Cheng YL
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):250-4. PubMed ID: 16677505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
    Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
    Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line.
    Lee SJ; Hwang JW; Yim H; Yim HJ; Woo SU; Suh SJ; Hyun JJ; Jung SW; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1299-307. PubMed ID: 24372723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel followed by castration improves outcomes in LNCaP prostate cancer-bearing severe combined immunodeficient mice.
    Tang Y; Khan MA; Goloubeva O; Lee DI; Jelovac D; Brodie AM; Hussain A
    Clin Cancer Res; 2006 Jan; 12(1):169-74. PubMed ID: 16397039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
    Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
    Ralstin MC; Gage EA; Yip-Schneider MT; Klein PJ; Wiebke EA; Schmidt CM
    Mol Cancer Res; 2006 Jun; 4(6):387-99. PubMed ID: 16778086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.